RankAlpha logo
Back to Rankings

ENVB

Enveric BiosciencesC
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
View Chart
+
Peers tracked
11
U.S. public peers
Grade Position
In line
vs peer average
ENVB vs peer average
63/100
ENVB vs. peer average (C vs. D)
Grade spread
A 2 · C 1 · D 3 · F 5
Graded peers loaded
Coverage
11 graded
100% of tracked

Peer overview

AKAN is the first available peer comparator.

Loose same-sector micro-cap screen candidate; no direct mechanistic, indication, or clinical comparability is established. Exclude from valuation benchmarking.

✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
Top peerAKANAkanda
ENVB
Enveric Biosciences
AKAN
Akanda
Grade
C
A
Momentum
97
78
Value
58
46
Sentiment
52
82
Setup Bias
Net —
-
Market Cap
-
-
Posture
Mixed
Constructive
Open Side-by-Side ComparisonCompare all

Grade position vs AKAN

ENVB / AKAN
Grade Position
In line
ENVB vs. peer average (C vs. D)
63/100
Momentum
97
ENVB
Value
58
ENVB
Sentiment
52
AKAN

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs ENVB
1
AKAN
AKAN
A
100/100
-2
2
CDIO
CDIO
F
20/100
+2
3
JAGX
JAGX
A
100/100
-2
4
ERNA
Ernexa Therapeutics Inc Common
F
20/100
+2
5
CURX
Curanex Pharmaceuticals Inc Common
F
20/100
+2
AKAN is the first peer returned for this comparison set.